← Leaderboards
Jacques Lemire
University Of California San Diego
$12,699
Attributed
$12,699
Total exposure
5
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$12,699 · 5
By mechanism
M01$12,699 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of California San Diego
Same institution · by research overlap
- Jerry A Schneider$14,686
- Teresa Dianne Langford$10,314,213
- Ewa Carrier$1,285,003
- Paul A Price$2,841,256
- Daniel Rene Salomon$16,462,808
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman Therapy EvaluationHuman Subject1,25 DihydroxycholecalciferolContractureCytotoxicityElasticityImmune SystemLungRespiratory FunctionSclerodermaSkin Disorder ChemotherapySteroid Hormone MetabolismSteroid MetabolismVitamin DPediatric PharmacologyKidney TransplantationPharmacokineticsHormone TherapyAtopic DermatitisArtificial ImmunosuppressionRacial /Ethnic DifferenceMultidrug ResistanceCaucasian American
Grant awards (29)
DIFFERENCES OF LATINOS AND CAUCASIANS WITH RENAL AND SKIN DISEASES ON TACROLIMUS$8,548
M01 · FY2005 · RR
RAD001 IN PEDIATRIC DE NOVO RENAL TRANSPLANT PATIENTS$610
M01 · FY2005 · RR
Difference of Latinos/Caucasians w/Renal/Skin Dis--FK506$3,541
M01 · FY2004 · RR
VITAMIN D METABOLITE, CALCITRIOL IN SCLERODERMA$0
M01 · FY2002 · RR
VITAMIN D METABOLITE, CALCITRIOL IN SCLERODERMA$0
M01 · FY2002 · RR
VITAMIN D METABOLITE, CALCITRIOL IN SCLERODERMA$0
M01 · FY2002 · RR
VITAMIN D METABOLITE, CALCITRIOL IN SCLERODERMA$0
M01 · FY2002 · RR
RAD001 IN PEDIATRIC STABLE RENAL TRANSPLANT RECIPIENTS$0
M01 · FY2002 · RR
RAD001 IN PEDIATRIC STABLE RENAL TRANSPLANT RECIPIENTS$0
M01 · FY2002 · RR
RAD001 IN PEDIATRIC STABLE RENAL TRANSPLANT RECIPIENTS$0
M01 · FY2002 · RR
RAD001 IN PEDIATRIC STABLE RENAL TRANSPLANT RECIPIENTS$0
M01 · FY2002 · RR
IV IGG TO LOWER ALLOSENSITIZATION &IMPROVE ALLOGRAFT SURVIVAL IN PEDIATRIC ESRD$0
M01 · FY2002 · RR
IV IGG TO LOWER ALLOSENSITIZATION &IMPROVE ALLOGRAFT SURVIVAL IN PEDIATRIC ESRD$0
M01 · FY2002 · RR
IV IGG TO LOWER ALLOSENSITIZATION &IMPROVE ALLOGRAFT SURVIVAL IN PEDIATRIC ESRD$0
M01 · FY2002 · RR
IV IGG TO LOWER ALLOSENSITIZATION &IMPROVE ALLOGRAFT SURVIVAL IN PEDIATRIC ESRD$0
M01 · FY2002 · RR
VITAMIN D METABOLITE, CALCITRIOL IN SCLERODERMA$0
M01 · FY2001 · RR
RAD001 IN PEDIATRIC STABLE RENAL TRANSPLANT RECIPIENTS$0
M01 · FY2001 · RR
RAD001 IN PEDIATRIC STABLE RENAL TRANSPLANT RECIPIENTS$0
M01 · FY2001 · RR
IV IGG TO LOWER ALLOSENSITIZATION &IMPROVE ALLOGRAFT SURVIVAL IN PEDIATRIC ESRD$0
M01 · FY2001 · RR
IV IGG TO LOWER ALLOSENSITIZATION &IMPROVE ALLOGRAFT SURVIVAL IN PEDIATRIC ESRD$0
M01 · FY2001 · RR
VITAMIN D METABOLITE, CALCITRIOL IN SCLERODERMA$0
M01 · FY2001 · RR
IV IGG TO LOWER ALLOSENSITIZATION &IMPROVE ALLOGRAFT SURVIVAL IN PEDIATRIC ESRD$0
M01 · FY2000 · RR
VITAMIN D METABOLITE, CALCITRIOL IN SCLERODERMA$0
M01 · FY2000 · RR
VITAMIN D METABOLITE, CALCITRIOL IN SCLERODERMA$0
M01 · FY2000 · RR
VITAMIN D METABOLITE, CALCITRIOL IN SCLERODERMA$0
M01 · FY2000 · RR
RAD001 IN PEDIATRIC STABLE RENAL TRANSPLANT RECIPIENTS$0
M01 · FY2000 · RR
RAD001 IN PEDIATRIC STABLE RENAL TRANSPLANT RECIPIENTS$0
M01 · FY2000 · RR
RAD001 IN PEDIATRIC STABLE RENAL TRANSPLANT RECIPIENTS$0
M01 · FY2000 · RR
IV IGG TO LOWER ALLOSENSITIZATION &IMPROVE ALLOGRAFT SURVIVAL IN PEDIATRIC ESRD$0
M01 · FY2000 · RR